首頁 › 非肌層浸潤性膀胱癌 › 田納西州 › Nashville
Nashville, TN 的 非肌層浸潤性膀胱癌 臨床試驗
8 項針對 非肌層浸潤性膀胱癌 的研究正在 Nashville（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
招募中2 期
- Urology Associates PC, Nashville
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
招募中1 期
- Urology Associates, P.C., Nashville
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
招募中2 期
- Urology Associates PC, Nashville
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
招募中1 期
- Sarah Cannon and HCA Research Institute, Nashville
- Tennessee Oncology, Nashville
- Vanderbilt University Medical Center, Nashville
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
招募中1/2 期
- Urology Associates, P.C., Nashville
- Vanderbilt Univerity Medical Center, Nashville
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
招募中觀察性研究
- Vanderbilt University Medical Center, Nashville
ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
招募中1/2 期
- Urology Associates, P.C., Nashville
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
招募中2 期
- Site 02-007 - Urology Associates, P. C, Nashville
其他城市的 非肌層浸潤性膀胱癌 試驗
- Columbus, OH10 項研究
- Dallas, TX10 項研究
- New York City, NY10 項研究
- Myrtle Beach, SC9 項研究
- Edison, NJ9 項研究
- Baltimore, MD8 項研究
- Syracuse, NY8 項研究
- Houston, TX7 項研究
- Indianapolis, IN7 項研究
- Birmingham, AL7 項研究
- Philadelphia, PA7 項研究
- Atlanta, GA7 項研究
Nashville 的其他研究
- 非小細胞肺癌97 項研究
- 乳癌81 項研究
- 轉移性癌症70 項研究
- 大腸直腸癌69 項研究
- 癌症（所有類型）65 項研究
- 卵巢癌49 項研究
- 前列腺癌43 項研究
- 肺癌40 項研究
- 頭頸部鱗狀細胞癌39 項研究
- 胰臟癌39 項研究
- 子宮內膜癌38 項研究
- 黑色素瘤33 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。